Metagenomi Therapeutics, Inc.
MGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001785279
In the last 90 days, Metagenomi Therapeutics, Inc. insiders filed 1 open-market purchase and 3 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $7.45M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Metagenomi Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 50
- +50 vs. Q4 2023
- Shares held
- 13.3M
- +13.3M vs. Q4 2023
- Total value
- $140.3M
- +$140.3M vs. Q4 2023
- New holders
- 50
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $7.45M |
| Q1 2026 | 48 | $8.65M |
| Q4 2025 | 56 | $11.0M |
| Q3 2025 | 58 | $14.2M |
| Q2 2025 | 69 | $10.4M |
| Q1 2025 | 79 | $13.5M |
| Q4 2024 | 77 | $38.8M |
| Q3 2024 | 67 | $25.3M |
| Q2 2024 | 54 | $49.6M |
| Q1 2024 | 50 | $140.3M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Metagenomi Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Macquarie Group Ltd | 355 | $4 | 0.00% | +355 | New |
| Larson Financial Group LLC | 50 | $528 | 0.00% | +50 | New |
| Principal Securities, Inc. | 54 | $570 | 0.00% | +54 | New |
| Tower Research Capital LLC (TRC) | 456 | $4.81K | 0.00% | +456 | New |
| Assetmark, Inc | 952 | $10.0K | 0.00% | +952 | New |
| UBS Group AG | 1,680 | $17.7K | 0.00% | +1,680 | New |
| Bank of America Corp | 3,149 | $33.2K | 0.00% | +3,149 | New |
| US Bancorp | 4,500 | $47.5K | 0.00% | +4,500 | New |
| Morgan Stanley | 9,205 | $97.1K | 0.00% | +9,205 | New |
| Resolute Partners Group | 10,000 | $105.5K | 0.02% | +10,000 | New |
| Legal & General Group Plc | 10,000 | $105.8K | 0.00% | +10,000 | New |
| Teacher Retirement System of Texas | 10,000 | $106.0K | 0.00% | +10,000 | New |
| Jane Street Group, LLC | 12,330 | $130.1K | 0.00% | +12,330 | New |
| Northern Trust Corp | 13,053 | $137.7K | 0.00% | +13,053 | New |
| JPMorgan Chase & Co | 13,747 | $145.0K | 0.00% | +13,747 | New |
| Qube Research & Technologies Ltd | 16,667 | $175.8K | 0.00% | +16,667 | New |
| Citigroup Inc | 16,668 | $175.8K | 0.00% | +16,668 | New |
| Laurion Capital Management LP | 20,000 | $211.0K | 0.01% | +20,000 | New |
| Two Sigma Investments, LP | 20,159 | $212.7K | 0.00% | +20,159 | New |
| Balyasny Asset Management LLC | 22,009 | $232.2K | 0.00% | +22,009 | New |
| Wells Fargo & Company | 24,894 | $262.6K | 0.00% | +24,894 | New |
| Bramshill Investments, LLC | 25,500 | $269.0K | 0.03% | +25,500 | New |
| Squarepoint Ops LLC | 26,488 | $279.4K | 0.00% | +26,488 | New |
| Charles Schwab Investment Management Inc | 30,148 | $318.1K | 0.00% | +30,148 | New |
| HRT Financial LP | 31,477 | $332.0K | 0.00% | +31,477 | New |
| LMR Partners LLP | 52,058 | $549.2K | 0.01% | +52,058 | New |
| Hudson Bay Capital Management LP | 66,666 | $703.3K | 0.01% | +66,666 | New |
| Geode Capital Management, LLC | 86,763 | $915.3K | 0.00% | +86,763 | New |
| Norges Bank | 107,892 | $1.14M | 0.00% | +107,892 | New |
| BlackRock Inc. | 114,324 | $1.21M | 0.00% | +114,324 | New |
| Ghisallo Capital Management LLC | 125,000 | $1.32M | 0.15% | +125,000 | New |
| Altitude Crest Partners Inc. | 133,333 | $1.41M | 0.60% | +133,333 | New |
| Vanguard Group Inc | 179,547 | $1.89M | 0.00% | +179,547 | New |
| Marshall Wace, LLP | 183,027 | $1.93M | 0.00% | +183,027 | New |
| ExodusPoint Capital Management, LP | 227,556 | $2.40M | 0.03% | +227,556 | New |
| Frazier Life Sciences Management, L.P. | 279,025 | $2.94M | 0.12% | +279,025 | New |
| Artal Group S.A. | 300,000 | $3.17M | 0.08% | +300,000 | New |
| Principal Financial Group Inc | 350,859 | $3.70M | 0.00% | +350,859 | New |
| Point72 Asset Management, L.P. | 371,100 | $3.92M | 0.01% | +371,100 | New |
| Pura Vida Investments, LLC | 461,283 | $4.87M | 3.31% | +461,283 | New |
| Deep Track Capital, LP | 466,232 | $4.92M | 0.14% | +466,232 | New |
| Sozo Ventures GP II, L.P. | 581,577 | $6.14M | 2.09% | +581,577 | New |
| Eventide Asset Management, LLC | 583,041 | $6.15M | 0.10% | +583,041 | New |
| Citadel Advisors LLC | 723,901 | $7.52M | 0.01% | +723,901 | New |
| Millennium Management LLC | 747,548 | $7.57M | 0.01% | +747,548 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 777,768 | $8.21M | 0.18% | +777,768 | New |
| PFM Health Sciences, LP | 1,267,002 | $13.4M | 0.66% | +1,267,002 | New |
| Farallon Capital Management, L.L.C. | 1,343,201 | $14.2M | 0.08% | +1,343,201 | New |
| Novo Holdings A/S | 1,739,175 | $18.3M | 1.27% | +1,739,175 | New |
| Ra Capital Management, L.P. | 1,744,415 | $18.4M | 0.23% | +1,744,415 | New |